DE2114607A1 - Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung - Google Patents

Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung

Info

Publication number
DE2114607A1
DE2114607A1 DE19712114607 DE2114607A DE2114607A1 DE 2114607 A1 DE2114607 A1 DE 2114607A1 DE 19712114607 DE19712114607 DE 19712114607 DE 2114607 A DE2114607 A DE 2114607A DE 2114607 A1 DE2114607 A1 DE 2114607A1
Authority
DE
Germany
Prior art keywords
formula
pyridyl
acid
acetic anhydride
pyridinecarboxaldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712114607
Other languages
German (de)
English (en)
Inventor
Auf Nichtnennung Antrag
Original Assignee
Karamchand Premchand Private Ltd., Gujarat State (Indien)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US00078142A priority Critical patent/US3748325A/en
Priority to GB47210/70A priority patent/GB1298603A/en
Priority to CA108,437A priority patent/CA940927A/en
Application filed by Karamchand Premchand Private Ltd., Gujarat State (Indien) filed Critical Karamchand Premchand Private Ltd., Gujarat State (Indien)
Priority to DE19712114607 priority patent/DE2114607A1/de
Priority to FR7111081A priority patent/FR2131843B1/fr
Priority to CH491971A priority patent/CH556847A/de
Publication of DE2114607A1 publication Critical patent/DE2114607A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712114607 1970-04-06 1971-03-26 Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung Pending DE2114607A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US00078142A US3748325A (en) 1970-04-06 1970-10-05 Process for the preparation of quinazolinone derivatives
GB47210/70A GB1298603A (en) 1970-04-06 1970-10-05 Quinazolinone derivatives
CA108,437A CA940927A (en) 1970-04-06 1971-03-23 Process for the preparation of quinazolinone compounds
DE19712114607 DE2114607A1 (de) 1970-04-06 1971-03-26 Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung
FR7111081A FR2131843B1 (cg-RX-API-DMAC10.html) 1970-04-06 1971-03-30
CH491971A CH556847A (de) 1970-04-06 1971-04-05 Verfahren zur herstellung neuer chinazolinon-derivate.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN126066 1970-04-06
DE19712114607 DE2114607A1 (de) 1970-04-06 1971-03-26 Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung
FR7111081A FR2131843B1 (cg-RX-API-DMAC10.html) 1970-04-06 1971-03-30
CH491971A CH556847A (de) 1970-04-06 1971-04-05 Verfahren zur herstellung neuer chinazolinon-derivate.

Publications (1)

Publication Number Publication Date
DE2114607A1 true DE2114607A1 (de) 1972-10-05

Family

ID=27428832

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712114607 Pending DE2114607A1 (de) 1970-04-06 1971-03-26 Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung

Country Status (6)

Country Link
US (1) US3748325A (cg-RX-API-DMAC10.html)
CA (1) CA940927A (cg-RX-API-DMAC10.html)
CH (1) CH556847A (cg-RX-API-DMAC10.html)
DE (1) DE2114607A1 (cg-RX-API-DMAC10.html)
FR (1) FR2131843B1 (cg-RX-API-DMAC10.html)
GB (1) GB1298603A (cg-RX-API-DMAC10.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998038187A1 (en) * 1997-02-28 1998-09-03 Pfizer Products Inc. Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
US5962457A (en) * 1996-05-15 1999-10-05 Pfizer Inc. 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
US6303615B1 (en) 1996-05-15 2001-10-16 Pfizer Inc 2,3 disubstituded-4(3H)-quinazolinones
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
WO2006087393A3 (en) * 2005-02-21 2009-08-27 Relivia S.R.L. Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832879A (en) * 1980-03-04 1989-05-23 Basf Aktiengesellchaft Substituted 3-fluoroalkoxybenzoyl halides and their preparation
JPH064584B2 (ja) * 1984-02-29 1994-01-19 沢井製薬株式会社 新規アニリド誘導体
WO1992013535A1 (en) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
US5283247A (en) * 1991-02-06 1994-02-01 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones
ATE267817T1 (de) * 1997-02-28 2004-06-15 Pfizer Prod Inc Atropisomere von 3-aryl-4(3h)-chinazolinonen und ihre verwendung als ampa-rezeptor
US9216177B2 (en) 2011-02-28 2015-12-22 Drexel University Small molecular inhibitors of RAD51 recombinase and methods thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH430733A (de) * 1963-04-25 1967-02-28 Eprova Ag Verfahren zur Herstellung von neuen Chinazolinon-Derivaten

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962457A (en) * 1996-05-15 1999-10-05 Pfizer Inc. 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
US6303615B1 (en) 1996-05-15 2001-10-16 Pfizer Inc 2,3 disubstituded-4(3H)-quinazolinones
WO1998038187A1 (en) * 1997-02-28 1998-09-03 Pfizer Products Inc. Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
US6380204B1 (en) 1997-02-28 2002-04-30 Pfizer Inc Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and CNS-trauma related conditions
US6323208B1 (en) 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
WO2006087393A3 (en) * 2005-02-21 2009-08-27 Relivia S.R.L. Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders

Also Published As

Publication number Publication date
GB1298603A (en) 1972-12-06
US3748325A (en) 1973-07-24
FR2131843B1 (cg-RX-API-DMAC10.html) 1974-05-24
FR2131843A1 (cg-RX-API-DMAC10.html) 1972-11-17
CH556847A (de) 1974-12-13
CA940927A (en) 1974-01-29

Similar Documents

Publication Publication Date Title
DE3441975C2 (cg-RX-API-DMAC10.html)
DE2114607A1 (de) Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung
DE2164058B2 (de) Basisch substituierte Benzylphthalazinon-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und diese Produkte enthaltende pharmazeutische Präparate
DE2258036A1 (de) Verfahren zur herstellung von benzo eckige klammer auf b eckige klammer zu thiophen-derivaten
DE2410938A1 (de) Chinazolinderivate und diese enthaltende arzneimittel
DE2007345A1 (de) Neue substituierte Hexahydroimidazochinoline und deren Säureanlagerungssalze
DE2322486C2 (de) as-Triazino [5,6-c] chinolin und seine Salze, Verfahren zur Herstellung derselben sowie diese Verbindungen enthaltende Arzneimittel
CH637391A5 (de) Therapeutisch wirksame 3-(1-piperazinyl)-1,2,4-benzotriazine und ihre n-oxide.
DE2456098C3 (de) Xanthen- und Thioxanthen-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3438244C2 (cg-RX-API-DMAC10.html)
DE2000030B2 (de) 3 Alkoxy und 3 Phenoxy 2 (diphenyl hydroxy)methyl propylamine und diese enthaltende Arzneimittel
DE3129718C2 (cg-RX-API-DMAC10.html)
DE2703522C2 (cg-RX-API-DMAC10.html)
DE2359359A1 (de) Fluor-substituierte thioxanthene und verfahren zu deren herstellung sowie diese enthaltende pharmazeutische mittel
DE2134880C3 (de) Thieno-pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3129719C2 (de) Pharmazeutisches Mittel
DE1770177A1 (de) Monoaryl-substituierte Oxazole
DE2641291A1 (de) 2-cyano-3- oder 4-(substituiertes amino)-oxanilsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
AT295516B (de) Verfahren zur Herstellung neuer cyclischer Amidine und ihrer Salze
CH643833A5 (de) Aminoisochinolinderivate, verfahren zur herstellung derselben und solche verbindungen enthaltende arzneimittel.
AT251584B (de) Verfahren zur Herstellung von neuen 4(3H)-Chinazolinon-Derivaten
DE2101275A1 (de) Neue Chinazolinen-Verbindungen und Verfahren zu ihrer Herstellung
AT216152B (de) Verfahren zur Herstellung von Diestern der Deserpidinsäure und deren Salzen
DE871897C (de) Verfahren zur Herstellung von heterocyclischen Aminoverbindungen
DE1942854A1 (de) Neue substituierte 3-Amino-4-halogensydnonimine